Wells Fargo’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Wells Fargo’s Portfolio GRTS Stock Details GRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-143,100	Closed	-$368K	–	7615
2024 Q1	$368K	Buy	+143,100	New	+$350K	﹤0.01%	4088

Other funds holding GRTS

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

EWA

EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return

Wells Fargo's GRTS Position: Q4 2024 in Review

Wells Fargo sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q4 2024, closing a stake of 29,251 shares — an estimated $17K sold.

Wells Fargo first reported a position in GRTS in Q3 2018 and held it in 25 quarters. The position peaked at $2.37M in Q3 2021. 6 funds tracked by Wall St. Rank hold GRTS as of Q4 2024.

Wells Fargo reported no remaining Gritstone bio, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Wells Fargo sold 29,251 Gritstone bio, Inc. Common Stock shares in Q4 2024, an estimated $17K.
Wells Fargo first reported a position in Gritstone bio, Inc. Common Stock in Q3 2018 and held it in 25 quarters.
Wells Fargo's Gritstone bio, Inc. Common Stock position peaked at $2.37M in Q3 2021.
6 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q4 2024.

Based on Wells Fargo's 13F filing for Q4 2024, filed 13 Feb 2025.